Glassman Wealth Services Ironwood Pharmaceuticals Inc Transaction History

Glassman Wealth Services

  • $593 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$10.86 - $13.95 $162 - $209
-15 Reduced 8.15%
169 $2,000
Q3 2021

Nov 10, 2021
BUY
$11.92 - $13.92 $178 - $208
15 Added 8.88%
184 $2,000
Q3 2020

Nov 09, 2020
BUY
$8.99 - $10.74 $890 - $1,063
99 Added 141.43%
169 $2,000
Q1 2019

May 10, 2019
BUY
$8.27 - $12.73 $578 - $891
70 New
70 $1,000

Others Institutions Holding IRWD

# of Institutions
244
Shares Held
163M
Call Options Held
11.5M
Put Options Held
12.9K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $230M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Glassman Wealth Services Portfolio

Follow Glassman Wealth Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email